Stay updated on Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Added a dedicated Locations section highlighting Illinois as a study site. Removed the separate Illinois Locations entry and the HHS Vulnerability Disclosure link in the prior revision.
    Difference
    0.2%
    Check dated 2025-12-23T22:26:38.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Minor backend version updates (from v3.2.0 to v3.3.2) with no changes to study content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T13:31:42.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Deletion of the site-wide notice about a lapse in government funding and NIH Clinical Center status; it does not affect the study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:19:49.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    No significant content changes detected; core study information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-27T20:58:45.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Core content updated with a government-operating-status notice and a version upgrade to v3.2.0, replacing the previous v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T07:54:20.000Z thumbnail image
  9. Check
    96 days ago
    Change Detected
    Summary
    - Updated revision from v3.0.2 to v3.1.0 - Added new contact details (phone numbers and email) for Massimo Cristofanilli and general support
    Difference
    0.1%
    Check dated 2025-09-29T04:15:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Carboplatin in Metastatic Breast Cancer Clinical Trial page.